Fujiwara. 1997. A mechanism underlying synergy between IL-12 and IFN- -inducing factor in enhanced production of IFN- . J. Immunol. 159:2125–2131. 31. Heath, V.L., E. Murphy, C. Crain, M. Tomlinson, and A. O’Garra. 2000. TGF- 1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur. J. Immunol. 30:2639–2649. 32. Szabo, S.J., A.S. Dighe, U. Gubler, K.M. Murphy. 1997. Regulation of the interleukin (IL)-12R 2 subunit expres- sion in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817–824. 33. Segal, B.M., and E.M. Shevach. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184:771– 775. 34. Xu, H., L.V. Rizzo, P.B. Silver, and R.R. Caspi. 1997. Uveitogenicity is associated with a Th1-like lymphokine pro- file: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell. Im- munol. 178:69–78. 35. Leite-de-Moraes, M.C., A. Hameg, M. Pacilio, Y. Koezuka, M. Taniguchi, L. Van Kaer, E. Schneider, M. Dy, and A. Herbelin. 2000. IL-18 enhacnes IL-4 production by ligand- activated NK T lymphocytes: a pro-Th2 effect of IL-18 ex- erted through NK T cells. J. Immunol. 166:945–951. 153 Smeltz et al.